Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06617845 · ClinicalTrials.gov registry record · NA
Optimizing Brain Stimulation Parameters
A NA study of Epilepsy; Seizure, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06617845 is a NA study of Epilepsy; Seizure that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 779-participant average among 4 other Epilepsy; Seizure trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06617845, a NA study of Epilepsy; Seizure, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
A primary purpose of this study is to better understand what stimulation parameters work best for patients. For example, for Deep Brain Stimulation (DBS) of the Anterior Nucleus of the Thalamus (ANT), it is not clear what stimulation frequency leads is most effective. This study will help assess the effectiveness of low frequency or high frequency stimulation.
Conditions Studied
Interventions
- DEVICE Stimulation Set A and B
Study Locations (1)
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-10-20 |
| Est. Completion | 2028-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06617845
The ClinicalTrials.gov registry entry for NCT06617845 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 779-participant average among 4 other Epilepsy; Seizure trials with a reported enrollment target (96% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Epilepsy; Seizure appearing as the primary indexed condition, and to 1 intervention - of which Stimulation Set A and B is the first listed.
NCT06617845 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06617845 about?
NCT06617845 is a clinical study titled "Optimizing Brain Stimulation Parameters". A primary purpose of this study is to better understand what stimulation parameters work best for patients. For example, for Deep Brain Stimulation (DBS) of the Anterior Nucleus of the Thalamus (ANT), it is not clear what stimulation frequency leads is most effective. This study will help assess the...
What is the current status of trial NCT06617845?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2020-10-20. Estimated completion is 2028-09-01.
What conditions does trial NCT06617845 study?
This clinical trial studies the following conditions: Epilepsy; Seizure.
What interventions are being tested in trial NCT06617845?
The interventions under investigation include: Stimulation Set A and B (DEVICE).
Who is sponsoring clinical trial NCT06617845?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06617845 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy; Seizure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Thalamus Seizure Detection With a Deep Brain Stimulator System
RECRUITING · NA
-
Forecasting Seizures Using Intelligent Wearable Technology for Health Tracking
RECRUITING · NA
-
Sleep Spindles and Memory in Rolandic Epilepsy
RECRUITING · NA
-
Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.